The neuroleptic antipsychotic derivate thioridazine has been shown to increase the susceptibility of a methicillin-resistant Staphylococcus aureus (MRSA) isolate towards dicloxacillin. The aim of this study was to investigate the combinatorial effect of the two drugs on a broad selection of staphylococcal strains by analyzing a large collection of MRSA strains carrying different types of SCCmec, as well as MSSA strains. Transcription and translation of the resistance marker PBP2a encoded by mecA within the SCCmec cassette were analyzed by primer extension and western blotting. We observed increased susceptibility to dicloxacillin in the presence of thioridazine in all tested MRSA isolates. In contrast to previously published results, the synergistic effect was also applicable to methicillin-susceptible S. aureus (MSSA). We conclude that the combination of dicloxacillin and thioridazine potentiates the killing effect against S. aureus in a broad selection of clinical isolates. Additionally, the study indicates that the killing effect by the combinatorial treatment is independent of PBP2a-mediated resistance mechanisms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.resmic.2012.10.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of a Hypothetical Protein (PBJ89160.1) from Exhibits a New Insight on Nutritional Virulence and Molecular Docking to Uncover a Therapeutic Target.
Evol Bioinform Online
November 2024
Department of Biotechnology and Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Article Synopsis
- The study aims to enhance understanding of the bacterial meningitis-causing diplococcus by identifying a functional protein that could be targeted for future treatments.
- Using a hypothetical protein (HP), researchers employed various bioinformatics methods and homology modeling to predict the protein's structure and function.
- Results indicated that HP is acidic and soluble, is localized in the periplasm, and Loperamide shows the best potential as a therapeutic agent by inhibiting the protein's transporter activity.
Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens.
Antibiotics (Basel)
September 2024
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain.
Intracellular bacterial pathogens pose significant public health challenges due to their ability to evade immune defenses and conventional antibiotics. Drug repurposing has recently been explored as a strategy to discover new therapeutic uses for established drugs to combat these infections. Utilizing high-throughput screening, bioinformatics, and systems biology, several existing drugs have been identified with potential efficacy against intracellular bacteria.
View Article and Find Full Text PDFIn silico study of some plant compounds as potential anticancer agents targeting MALT1 allosteric domain.
J Biomol Struct Dyn
September 2024
Department of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria.
Article Synopsis
- MALT1 is a crucial protein involved in immune responses, and its unusual signaling is linked to various diseases, including cancer, making it a target for new therapies.
- The study aimed to identify plant-based small molecules that could bind to MALT1 using computational methods, screening 34 compounds for their effectiveness.
- Cyanidin emerged as a promising allosteric inhibitor of MALT1, showing better binding and stability than the control drug thioridazine, but further testing is necessary to confirm its effectiveness in treating cancer and related diseases.
Stimuli-Responsive Hydrogels Potentiating Photothermal Therapy against Cancer Stem Cell-Induced Breast Cancer Metastasis.
ACS Nano
July 2024
School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Guangdong 518172, China.
Article Synopsis
- Cancer stem cells (CSCs) in breast cancer contribute to drug resistance, making treatment challenging despite existing drug developments.
- A new thermoresponsive hydrogel system is created that combines a photothermal agent and thioridazine (THZ), allowing for controlled drug delivery triggered by light, enhancing chemotherapy effectiveness.
- This system shows promising results in preclinical studies by improving drug accumulation in tumors and significantly reducing CSCs, thus minimizing tumor recurrence and spread in mice.
Novel regimens of phytopolyphenols and celecoxib enhancing efficacy and selectivity of anticancer effects of chemotherapeutic agents on cultured cancer cells.
J Dent Sci
July 2024
School of Dentistry, College of Oral Medicine, Chung Shan Medical University, Taichung, Taiwan.
Background/purpose: Explorations of novel regimens enhancing efficacy and selectivity of chemotherapeutic agents are urgent to solve the problems of cancer therapy. This study aimed to explore synergistic anticancer effects of novel regimens of phytopolyphenols [curcumin (C), tea polyphenols (G) or GC] with celecoxib (Cl) and ZnSO.
Materials And Methods: Antiproliferative effects of drugs on cultured cancer cells and pathogenic biofilms were assayed by MTT and optical density (OD600) respectively; their inhibition on efflux pump (Na-K-ATPase) was measured by colorimetric methods.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!